Gene · 8019
Papers2,104
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,104
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Liquid-Liquid Phase Separation Sheds New Light upon Cardiovascular Diseases. | Int J Mol Sci | 2023 | 37895097 | PubTator, text mining | PubMed |
| Sarcopenia in liver cirrhosis: perspectives from epigenetics and microbiota. | Front Med (Lausanne) | 2023 | 37881635 | PubTator, text mining | PubMed |
| Mutate and Conjugate: A Method to Enable Rapid In-Cell Target Validation. | ACS Chem Biol | 2023 | 37874862 | PubTator, text mining | PubMed |
| BRD2 protects the rat H9C2 cardiomyocytes from hypoxia‑reoxygenation injury by targeting Nrf2/HO‑1 signaling pathway. | Exp Ther Med | 2023 | 37869639 | PubTator, text mining | PubMed |
| Epigenetic Modulators as Therapeutic Agents in Cancer. | Int J Mol Sci | 2023 | 37834411 | PubTator, text mining | PubMed |
| Global mapping of RNA-chromatin contacts reveals a proximity-dominated connectivity model for ncRNA-gene interactions. | Nat Commun | 2023 | 37770513 | PubTator, text mining | PubMed |
| BET Inhibitor JQ1 Attenuates Feline Leukemia Virus DNA, Provirus, and Antigen Production in Domestic Cat Cell Lines. | Viruses | 2023 | 37766260 | PubTator, text mining | PubMed |
| Recent Developments in Vaccine Design: From Live Vaccines to Recombinant Toxin Vaccines. | Toxins (Basel) | 2023 | 37755989 | PubTator, text mining | PubMed |
| Pharmacological inhibition of bromodomain and extra-terminal proteins induces an NRF-2-mediated antiviral state that is subverted by SARS-CoV-2 infection. | PLoS Pathog | 2023 | 37747932 | PubTator, text mining | PubMed |
| Selectivity Mechanism of Pyrrolopyridone Analogues Targeting Bromodomain 2 of Bromodomain-Containing Protein 4 from Molecular Dynamics Simulations. | ACS Omega | 2023 | 37744850 | PubTator, text mining | PubMed |
| Methylation of BRD4 by PRMT1 regulates BRD4 phosphorylation and promotes ovarian cancer invasion. | Cell Death Dis | 2023 | 37737256 | PubTator, text mining | PubMed |
| A new vulnerability to BET inhibition due to enhanced autophagy in BRCA2 deficient pancreatic cancer. | Cell Death Dis | 2023 | 37735513 | PubTator, text mining | PubMed |
| Pervasive mislocalization of pathogenic coding variants underlying human disorders. | bioRxiv | 2023 | 37732209 | PubTator, text mining | PubMed |
| Molecular profiling and specific targeting of gemcitabine-resistant subclones in heterogeneous pancreatic cancer cell populations. | Front Oncol | 2023 | 37719017 | PubTator, text mining | PubMed |
| Targeting the epigenetic reader "BET" as a therapeutic strategy for cancer. | Bioorg Chem | 2023 | 37683545 | PubTator, text mining | PubMed |
| NUT carcinoma of the submandibular gland: A case report. | Cancer Rep (Hoboken) | 2023 | 37680121 | PubTator, text mining | PubMed |
| PROTAC chemical probes for histone deacetylase enzymes. | RSC Chem Biol | 2023 | 37654508 | PubTator, text mining | PubMed |
| Activity-based profiling of cullin-RING E3 networks by conformation-specific probes. | Nat Chem Biol | 2023 | 37653169 | PubTator, text mining | PubMed |
| How many kinases are druggable? A review of our current understanding. | Biochem J | 2023 | 37642371 | PubTator, text mining | PubMed |
| Insights into the Mechanism of Curaxin CBL0137 Epigenetic Activity: The Induction of DNA Demethylation and the Suppression of BET Family Proteins. | Int J Mol Sci | 2023 | 37629054 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8019/papers?page=9